NM_005045.4:c.2466-7dupT

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS1

The NM_005045.4(RELN):​c.2466-7dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0622 in 1,051,372 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.072 ( 0 hom. )

Consequence

RELN
NM_005045.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.884

Publications

1 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
RELN Gene-Disease associations (from GenCC):
  • lissencephaly with cerebellar hypoplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Norman-Roberts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
  • familial temporal lobe epilepsy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ankylosing spondylitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 7-103630182-G-GA is Benign according to our data. Variant chr7-103630182-G-GA is described in ClinVar as [Benign]. Clinvar id is 195496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000354 (49/138536) while in subpopulation AFR AF = 0.000344 (13/37754). AF 95% confidence interval is 0.000203. There are 0 homozygotes in GnomAd4. There are 23 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.2466-7dupT splice_region_variant, intron_variant Intron 19 of 64 ENST00000428762.6 NP_005036.2 P78509-1
RELNNM_173054.3 linkc.2466-7dupT splice_region_variant, intron_variant Intron 19 of 63 NP_774959.1 P78509-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.2466-7_2466-6insT splice_region_variant, intron_variant Intron 19 of 64 5 NM_005045.4 ENSP00000392423.1 P78509-1

Frequencies

GnomAD3 genomes
AF:
0.000332
AC:
46
AN:
138474
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000209
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00138
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000284
Gnomad OTH
AF:
0.000538
GnomAD2 exomes
AF:
0.0455
AC:
4612
AN:
101368
AF XY:
0.0444
show subpopulations
Gnomad AFR exome
AF:
0.0289
Gnomad AMR exome
AF:
0.0619
Gnomad ASJ exome
AF:
0.0692
Gnomad EAS exome
AF:
0.0408
Gnomad FIN exome
AF:
0.0628
Gnomad NFE exome
AF:
0.0353
Gnomad OTH exome
AF:
0.0573
GnomAD4 exome
AF:
0.0716
AC:
65364
AN:
912836
Hom.:
0
Cov.:
23
AF XY:
0.0697
AC XY:
31188
AN XY:
447198
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0753
AC:
1490
AN:
19784
American (AMR)
AF:
0.0517
AC:
1163
AN:
22500
Ashkenazi Jewish (ASJ)
AF:
0.0726
AC:
970
AN:
13358
East Asian (EAS)
AF:
0.0573
AC:
1166
AN:
20354
South Asian (SAS)
AF:
0.0488
AC:
2172
AN:
44490
European-Finnish (FIN)
AF:
0.0534
AC:
1571
AN:
29408
Middle Eastern (MID)
AF:
0.0485
AC:
186
AN:
3836
European-Non Finnish (NFE)
AF:
0.0746
AC:
53976
AN:
723348
Other (OTH)
AF:
0.0747
AC:
2670
AN:
35758
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.258
Heterozygous variant carriers
0
8169
16338
24507
32676
40845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2412
4824
7236
9648
12060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000354
AC:
49
AN:
138536
Hom.:
0
Cov.:
32
AF XY:
0.000343
AC XY:
23
AN XY:
67028
show subpopulations
African (AFR)
AF:
0.000344
AC:
13
AN:
37754
American (AMR)
AF:
0.000288
AC:
4
AN:
13896
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3294
East Asian (EAS)
AF:
0.000210
AC:
1
AN:
4766
South Asian (SAS)
AF:
0.000226
AC:
1
AN:
4420
European-Finnish (FIN)
AF:
0.00138
AC:
11
AN:
7944
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
0.000284
AC:
18
AN:
63454
Other (OTH)
AF:
0.000532
AC:
1
AN:
1880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0634
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 14, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Oct 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs571882672; hg19: chr7-103270629; COSMIC: COSV59022496; COSMIC: COSV59022496; API